BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33073380)

  • 1. F cell numbers are associated with an X-linked genetic polymorphism and correlate with haematological parameters in patients with sickle cell disease.
    Urio F; Nkya S; Rooks H; Mgaya JA; Masamu U; Zozimus Sangeda R; Mmbando BP; Brumat M; Mselle T; Menzel S; Luzzatto L; Makani J
    Br J Haematol; 2020 Dec; 191(5):888-896. PubMed ID: 33073380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
    El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
    Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon.
    Wonkam A; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Cooper RS; Tayo B; Lettre G; Ngogang J
    PLoS One; 2014; 9(3):e92506. PubMed ID: 24667352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania.
    Mtatiro SN; Makani J; Mmbando B; Thein SL; Menzel S; Cox SE
    Am J Hematol; 2015 Jan; 90(1):E1-4. PubMed ID: 25263325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease.
    Maier-Redelsperger M; Noguchi CT; de Montalembert M; Rodgers GP; Schechter AN; Gourbil A; Blanchard D; Jais JP; Ducrocq R; Peltier JY
    Blood; 1994 Nov; 84(9):3182-8. PubMed ID: 7524767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
    Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
    Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
    Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin.
    Ngo DA; Aygun B; Akinsheye I; Hankins JS; Bhan I; Luo HY; Steinberg MH; Chui DH
    Br J Haematol; 2012 Jan; 156(2):259-64. PubMed ID: 22017641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal hemoglobin in sickle cell anemia: genetic studies of the Arab-Indian haplotype.
    Ngo D; Bae H; Steinberg MH; Sebastiani P; Solovieff N; Baldwin CT; Melista E; Safaya S; Farrer LA; Al-Suliman AM; Albuali WH; Al Bagshi MH; Naserullah Z; Akinsheye I; Gallagher P; Luo HY; Chui DH; Farrell JJ; Al-Ali AK; Alsultan A
    Blood Cells Mol Dis; 2013 Jun; 51(1):22-6. PubMed ID: 23465615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease.
    Hebert N; Rakotoson MG; Bodivit G; Audureau E; Bencheikh L; Kiger L; Oubaya N; Pakdaman S; Sakka M; Di Liberto G; Chadebech P; Vingert B; Pirenne F; Galactéros F; Cambot M; Bartolucci P
    Am J Hematol; 2020 Nov; 95(11):1235-1245. PubMed ID: 32681733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy.
    Borba R; Lima CS; Grotto HZ
    J Clin Lab Anal; 2003; 17(2):66-72. PubMed ID: 12640630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between foetal haemoglobin and haematological indices in children with sickle cell anaemia from South Western Nigeria.
    Akinlosotu MA; Adegoke SA; Oseni SB; Adeodu OO
    Niger Postgrad Med J; 2017; 24(4):195-200. PubMed ID: 29355156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease.
    Marcus SJ; Kinney TR; Schultz WH; O'Branski EE; Ware RE
    Am J Hematol; 1997 Jan; 54(1):40-6. PubMed ID: 8980259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.
    Liu L; Pertsemlidis A; Ding LH; Story MD; Steinberg MH; Sebastiani P; Hoppe C; Ballas SK; Pace BS
    Exp Biol Med (Maywood); 2016 Apr; 241(7):706-18. PubMed ID: 27022141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease.
    el-Hazmi MA; al-Momen A; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F; Warsy AS
    Acta Haematol; 1995; 94(3):128-34. PubMed ID: 7502628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-Transcriptional Genetic Silencing of
    Esrick EB; Lehmann LE; Biffi A; Achebe M; Brendel C; Ciuculescu MF; Daley H; MacKinnon B; Morris E; Federico A; Abriss D; Boardman K; Khelladi R; Shaw K; Negre H; Negre O; Nikiforow S; Ritz J; Pai SY; London WB; Dansereau C; Heeney MM; Armant M; Manis JP; Williams DA
    N Engl J Med; 2021 Jan; 384(3):205-215. PubMed ID: 33283990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary persistence of hemoglobin F is protective against red cell sickling. A case report and brief review.
    Sokolova A; Mararenko A; Rozin A; Podrumar A; Gotlieb V
    Hematol Oncol Stem Cell Ther; 2019 Dec; 12(4):215-219. PubMed ID: 29079125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients.
    Bhatnagar P; Purvis S; Barron-Casella E; DeBaun MR; Casella JF; Arking DE; Keefer JR
    J Hum Genet; 2011 Apr; 56(4):316-23. PubMed ID: 21326311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased HbF in sickle cell anemia is determined by a factor linked to the beta S gene from one parent.
    Milner PF; Leibfarth JD; Ford J; Barton BP; Grenett HE; Garver FA
    Blood; 1984 Jan; 63(1):64-72. PubMed ID: 6197115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models.
    Milton JN; Gordeuk VR; Taylor JG; Gladwin MT; Steinberg MH; Sebastiani P
    Circ Cardiovasc Genet; 2014 Apr; 7(2):110-5. PubMed ID: 24585758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.